Tuesday, June 30
Los Angeles Herald
Sign in
Latest
Los Angeles L.A.'s Noncitizen Voting Measure Is Pulled From the November BallotBusiness Nike Tops Estimates on a Tariff Refund, but China Sales Keep SlidingWorld China Moves to Shield Workers From AI Even as It Races to Lead in ItLos Angeles Moorpark Man Sentenced in the 2023 Death of Paul KesslerEntertainment What to Read This July: A Summer Reading ListPolitics Coloradans Vote in a Primary Testing the Democratic EstablishmentEntertainment Broadway Cleaners Vote to Authorize a StrikeBusiness U.S. Stocks Post Their Best Quarter Since 2020Los Angeles L.A.'s Noncitizen Voting Measure Is Pulled From the November BallotBusiness Nike Tops Estimates on a Tariff Refund, but China Sales Keep SlidingWorld China Moves to Shield Workers From AI Even as It Races to Lead in ItLos Angeles Moorpark Man Sentenced in the 2023 Death of Paul KesslerEntertainment What to Read This July: A Summer Reading ListPolitics Coloradans Vote in a Primary Testing the Democratic EstablishmentEntertainment Broadway Cleaners Vote to Authorize a StrikeBusiness U.S. Stocks Post Their Best Quarter Since 2020

Topic: Anthropic

A pharmaceutical research laboratory.
Business
Tuesday, 6/30, 08:48 PM

Anthropic Pushes Into AI Drug Discovery With a New Research Platform

  • The artificial-intelligence company Anthropic has launched a research platform aimed at pharmaceutical and life-sciences labs and disclosed that it is running its own drug-discovery programs — moves that push the maker of the Claude chatbot into more direct competition with Google, OpenAI and Nvidia in the race to apply AI to medicine.

Anthropic — news and stories on this topic

This page collects all of the Los Angeles Herald's coverage of Anthropic. Follow the topic from one place: new stories appear here automatically as more is published. That way you stay on top of how the situation develops.

Looking for the bigger picture? Browse Los Angeles news, U.S. news, world news and politics, or head back to the front page for the day's top stories.